AXSM
Axsome Therapeutics, IncstockNASDAQ
Market OpenNov 17, 2026 10:07:08 AM EST
137.00USD-0.007%(-0.01)66,013
Pre-marketNov 17, 2026 9:27:30 AM EST
139.01USD+1.462%(+2.00)
Loading…
Loading…
7.19B
Healthcare
Biotechnology
CEO
Herriot Tabuteau
HQ
New York, NY, USA
Previous Close
$136.88
Beta
0.70
52-Week High
$260.19 2026-06-18
52-Week Low
$123.00 2026-11-02
SMA 50
$170.05
SMA 200
$196.81
Avg. Vol 10D
1.10M
Avg. Vol 30D
1.09M
Avg. Vol 90D
822,742
Relative Vol
0.06
52.60M
44.37M
84.35%
3,263,105
7.39%
3.35
52%/48%
61.28%
52.36%
0.2800%
500,000
649
4,931
19,570
865.3M
-157.3M
-3.05
-82.6M
-17.45
-175.59
Nov 16, 2026
Nov 14, 2026
Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027? ·
The Motley Fool+1 source
Nov 13, 2026
AXSM Profile
axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.
AXSM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 140.97 | 2026-11-10 | -2.99% | 2.881 |
| 1M | 157.14 | 2026-10-16 | -12.97% | 1.012 |
| 3M | 216.27 | 2026-08-17 | -36.76% | 0.888 |
| 6M | 227.40 | 2026-05-18 | -39.86% | 0.628 |
| 1Y | 145.56 | 2025-11-17 | -6.05% | 0.705 |
| 2Y | 92.45 | 2024-11-18 | +47.93% | — |
| 5Y | 34.55 | 2021-11-17 | +295.83% | 0.868 |
AXSM Stock Summary
Axsome Therapeutics, Inc (NASDAQ:AXSM) stock price today is $136.76, and today's volume is 62,135. AXSM is down 0.182% today. The 30 day average volume is 1.09M. AXSM market cap is $7.19B with 52.60M shares outstanding.